HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jong-Seok Kim Selected Research

Colonic Neoplasms (Colon Cancer)

10/2015Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity.
5/2013Apicularen A acetate induces cell death via AIF translocation and disrupts the microtubule network by down-regulating tubulin in HM7 human colon cancer cells.
7/2011Protein-bound polysaccharide from Phellinus linteus inhibits tumor growth, invasion, and angiogenesis and alters Wnt/β-catenin in SW480 human colon cancer cells.
3/2009Radiation-induced thymidine phosphorylase upregulation in rectal cancer is mediated by tumor-associated macrophages by monocyte chemoattractant protein-1 from cancer cells.
11/2007Apicularen A induces cell death through Fas ligand up-regulation and microtubule disruption by tubulin down-regulation in HM7 human colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jong-Seok Kim Research Topics

Disease

11Neoplasms (Cancer)
11/2023 - 11/2007
8Infections
02/2022 - 01/2015
7Tuberculosis (Tuberculoses)
01/2019 - 12/2011
5Colonic Neoplasms (Colon Cancer)
10/2015 - 11/2007
3Obesity
01/2023 - 01/2021
3Insulin Resistance
01/2023 - 07/2012
3Inflammation (Inflammations)
01/2021 - 02/2015
2Fatty Liver
01/2023 - 01/2023
2Body Weight (Weight, Body)
04/2022 - 01/2021
2Hypoxia (Hypoxemia)
01/2021 - 01/2018
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 05/2020
2Necrosis
01/2013 - 06/2012
1Nontuberculous Mycobacterium Infections
01/2024
1Hypertension (High Blood Pressure)
01/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2023
1Breast Neoplasms (Breast Cancer)
12/2022
1Colitis
04/2022
1Ulcerative Colitis
04/2022
1Wound Infection (Wound Infections)
02/2022
1Sepsis (Septicemia)
02/2022
1Non-alcoholic Fatty Liver Disease
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Amyloid Plaque
01/2021
1Premature Birth (Birth, Premature)
10/2020
1Fetal Growth Retardation (Intrauterine Growth Retardation)
10/2020
1Endometrial Neoplasms (Endometrial Cancer)
09/2020
1Endometriosis
01/2019
1Hepatic Encephalopathy
01/2018
1Starvation
01/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Hyperammonemia
01/2018
1Pneumonia (Pneumonitis)
05/2016
1Malnutrition (Nutritional Deficiencies)
09/2015

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2023 - 03/2009
6VaccinesIBA
01/2019 - 01/2015
4CytokinesIBA
04/2022 - 01/2013
3RNA (Ribonucleic Acid)IBA
11/2023 - 01/2015
3AntigensIBA
01/2018 - 12/2011
3TubulinIBA
01/2014 - 11/2007
3apicularen AIBA
01/2014 - 11/2007
2Glucose (Dextrose)FDA LinkGeneric
01/2023 - 02/2022
2InflammasomesIBA
01/2023 - 01/2021
2Messenger RNA (mRNA)IBA
01/2021 - 03/2009
2Polysaccharides (Glycans)IBA
01/2021 - 07/2011
2Peptides (Polypeptides)IBA
01/2021 - 01/2015
2InterleukinsIBA
01/2021 - 04/2015
2Docosahexaenoic AcidsIBA
05/2020 - 01/2011
2CateninsIBA
07/2011 - 01/2011
1Antitubercular AgentsIBA
01/2024
1HydrogelsIBA
01/2023
1L-Type Calcium Channels (Dihydropyridine Receptor)IBA
01/2023
1Verapamil (Calan)FDA LinkGeneric
01/2023
1Palmitic Acid (Hexadecanoic Acid)IBA
01/2023
1dimethyl sulfone (methylsulfonylmethane)IBA
01/2023
1Biomarkers (Surrogate Marker)IBA
12/2022
14-octyl itaconateIBA
04/2022
1itaconic acidIBA
04/2022
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
04/2022
1aconitate decarboxylaseIBA
04/2022
1Dextrans (Dextran)FDA Link
04/2022
1ChemokinesIBA
04/2022
1PolyphenolsIBA
01/2021
1Ellagic AcidIBA
01/2021
1Chlorogenic AcidIBA
01/2021
1cinnamic acidIBA
01/2021
1Blood Glucose (Blood Sugar)IBA
01/2021
1vitexinIBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Cadherins (E-Cadherin)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1amlexanox (Aphthasol)FDA Link
01/2021
1SaponinsIBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2021
1LipopolysaccharidesIBA
10/2020
1acteosideIBA
10/2020
1Mechanistic Target of Rapamycin Complex 1IBA
09/2020
1MTOR InhibitorsIBA
09/2020
1TOR Serine-Threonine KinasesIBA
09/2020
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
05/2020
1Toll-Like Receptor 2IBA
01/2019
1BCG VaccineFDA Link
01/2019
1Cytochromes c (Cytochrome c)IBA
01/2018
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2018
1Neuroprotective AgentsIBA
01/2018
1Malate Dehydrogenase (Dehydrogenase, Malate)IBA
01/2018
1Nortriptyline (Aventyl)FDA LinkGeneric
01/2018
1Subunit VaccinesIBA
05/2016
1Liposomes (Liposome)IBA
05/2016
1dimethyldioctadecylammonium (dimethyldioctadecylammonium chloride)IBA
05/2016
1monophosphoryl lipid AIBA
05/2016
1Toll-Like Receptor AgonistsIBA
10/2015
1Neoplasm Antigens (Tumor Antigens)IBA
10/2015
1IronIBA
09/2015

Therapy/Procedure

5Therapeutics
04/2022 - 01/2011
1Cutaneous Administration
01/2023
1Transdermal Patch
01/2023
1Catheters
02/2022
1Intraperitoneal Injections
10/2020
1Activities of Daily Living (ADL)
10/2020
1Immunotherapy
10/2015